Updated:
Terran Biosciences
Transforming the lives of patients with neurological and psychiatric illnesses | Terran is developing a broad portfolio of transformative therapeutics and...
Terran Biosciences
Transforming the lives of patients with neurological and psychiatric illnesses | Terran is developing a broad portfolio of transformative therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
Who leads investment decisions at Terran Biosciences?
The firm's leadership team is not publicly disclosed. It operates as a privately held asset manager focused on neuroscience and biotech investments, with decision-making likely concentrated among a small group of scientific and financial professionals.
What investment stages does Terran Biosciences target?
Terran Biosciences targets early- to mid-stage clinical investments, primarily in neurology and psychiatry. The firm focuses on de-risking novel drug candidates from academic labs and early-stage biotechs, often through structured milestone-based capital deployment.
Which therapeutic areas does Terran Biosciences focus on?
The firm concentrates on neuroscience and psychiatric conditions, including schizophrenia, depression, neurodegenerative disorders, and other central nervous system (CNS) indications. This specialization sets it apart from more generalist biotech investors.
Does Terran Biosciences invest in public or private companies?
The firm's public profile suggests a focus on private early-stage companies, particularly those in preclinical and Phase I development. There is no public record of public equity investments or fund commitments.
How does Terran Biosciences source proprietary deal flow?
Deal flow likely comes from academic research institutions, biotech incubators, and scientific conferences. The firm's deep domain expertise in neuroscience may allow it to identify and evaluate opportunities that generalist investors overlook.
What is the relationship between Terran Biosciences and other asset managers?
No direct relationship with other asset managers or family offices has been disclosed. The firm appears to operate independently, as a specialized investment vehicle focused solely on neuroscience and biotech.
Does Terran Biosciences participate in fund commitments or only direct deals?
The firm's structure suggests a direct investment approach, likely making principal investments in individual portfolio companies. No public information indicates participation in fund-of-funds or external fund commitments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: